-
Velan-Repertoire Releases Detailed Presentation on the Need for Board Change at Radius Health and Sends Letter to Stockholders
21 Jun 2022 11:27 GMT
… of the largest stockholders of Radius Health, Inc. (“Radius” or the … Reconstitution is Necessary to Fix Radius Health, Inc." can be … filed our initial Schedule 13D). IPO June 6, 2014. Mr. … Management Sends Letter to Radius Health Board of Directors
View …
-
Velan-Repertoire Group Files Definitive Proxy Materials in Connection With Radius Health 2022 Annual Meeting
07 Jun 2022 11:27 GMT
… of the largest stockholders of Radius Health, Inc. (“Radius” or the “ … own approximately 7.7% of Radius Health, Inc.’s (“Radius” or …
3 year
5 year
Sinco IPO
Since Mr. Martin
Joined
Radius … which has occurred since its IPO in 2014. Instead of …
-
Reevaluating Radius Health
24 Feb 2022 21:09 GMT
… analysis follows below Company Overview: Radius Health, Inc. (NASDAQ:RDUS) is a … for the Biotech Forum, Busted IPO Forum, and Insiders Forum
-
The Daily Biotech Pulse: Mixed Tidings From Novavax, Radius Health Out-licenses Breast Cancer Drug, 3 IPOs
24 Jul 2020 11:43 GMT
… Pandemic
Stocks In Focus
Radius Health Out-licenses Breast Cancer … pre-market trading Friday, Radius Health shares were rising 9. … estimates.
On The Radar
IPOs
iTeos Therapeutics, a clinical … for patients, priced its initial public offering, or IPO, of 10.586 …
-
Revisiting Radius Health
14 Feb 2020 22:21 GMT
… analysis presented below. Company Overview: Radius Health, Inc. (NASDAQ:RDUS) is a … for the Biotech Forum, Busted IPO Forum, and Insiders Forum
I …
-
Biotech IPO Freeze Continues As Second Quarter Is Slowest In More Than A Decade
05 Jul 2022 21:41 GMT
… IPOs since 2009, according to a new report from IPO … plummeted to just 18 IPOs. Renaissance said factors holding … cases, companies are postponing IPO plans indefinitely. Bausch Health … pursue alternative financial strategies. Radius Health is going private via …
-
The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs
20 Jun 2021 14:52 GMT
… witnessed a host of an initial public offering, as IPO news flow resumed after … Dystrophy (Wednesday)
PWSA Meeting Presentation
Radius Health, Inc. (NASDAQ: RDUS): Data … for transthyretin amyloidosis (Saturday)
IPOs
IPO Pricings
Miromatrix Medical Inc., a …
-
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
07 May 2021 11:52 GMT
… open)
Radius Health, Inc. (NASDAQ: RDUS) (before the market open)
IPOs
Talaris Therapeutics … cell therapy company priced its initial public offering of 8.825 million shares … and substance addiction, priced its IPO of 3 million shares of …
-
Radius Health Appoints Jesper Høiland as President and Chief Executive Officer To Lead The Next Stage Of Growth and Value Creation As A Fully Integrated Commercial Biotech Company
17 Jul 2017 11:00 GMT
… 17, 2017 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company … pleased to welcome Jesper to Radius Health at this important time, and … the Company successfully completed its IPO, advanced multiple pipeline assets, and …
-
Radius Health Appoints Pharmaceutical Executive Jose Carmona as Chief Financial Officer
15 May 2017 11:00 GMT
… 15, 2017 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company … . Ward, President and CEO of Radius Health. “His recent transaction experience and … the Company successfully completed its IPO and established a solid financial …
About
© 1995-2025